"IONTOPHORESIS vs. PHONOPHORESIS" for Treatment of Subacromial Impingement Syndrome

Sponsor

Emre Şenocak (Other)

Overall Status

Completed

CT.gov ID

NCT06094361

Collaborator

(none)

Enrollment

Location

Arms

Actual Duration (Months)

4.3

Patients Per Site Per Month

Study Details

Study Description

Brief Summary

The aim of this study was to compare the effects of iontophoresis and phonophoresis applications added to conventional treatment on pain, range of motion, disability, and functional status in the shoulder region in patients with subacromial impingement syndrome.

Condition or Disease	Intervention/Treatment	Phase
Subacromial Impingement Syndrome	Procedure: Iontophoresis Intervention Procedure: Phonophoresis Procedure: Conventional Therapy	N/A

Detailed Description

Randomization: Forty-seven patients were assessed, and 43 completed the study in this randomized trial. The participants were divided into two groups (Iontophoresis:22 and Phonophoresis:21) using the online randomization software (www.randomizer.org). All patients gave written informed consent after being verbally informed about the study.

Assessment Period: Assessments were conducted twice, at the start and after completion of the 10-session treatment program.

Session Period: All treatment programs were delivered five days per week for two weeks. The total number of sessions was ten.

Analysis: The statistical analysis was performed using version 21 of the Statistical Package for the Social Sciences (SPSS).To verify normal distribution, the Shapiro-Wilk test and histogram curves were utilized. Descriptive statistics for parametric variables included mean, standard deviation, and percentage. Since the data exhibited normal distribution, independent sample T-tests were used for group comparison while paired sample T-tests were used to detect changes within the group. The significance level of p<0.05 was deemed acceptable for all analyses. For variables with nominal assessments, data were analyzed utilizing Yates Continuity Correction and Fisher's exact chi-square test.

The post hoc power of the study was calculated using Gpower 3.1.9.1 software. The resting VAS scores was taken as reference. In this context, Cohen's effect size was calculated as 1.00. When the alpha error was accepted as 5%, and effect size was 1.00, the post hoc power was found to be 94.27%.

Study Design

Study Type:

Interventional

Actual Enrollment :

43 participants

Allocation:

Randomized

Intervention Model:

Parallel Assignment

Intervention Model Description:

There were two separate groups in the study. The first group received iontophoresis and the other group received phonophoresis. The effects on treatment outcomes were compared.There were two separate groups in the study. The first group received iontophoresis and the other group received phonophoresis. The effects on treatment outcomes were compared.

Masking:

None (Open Label)

Primary Purpose:

Treatment

Official Title:

"IONTOPHORESIS vs. PHONOPHORESIS": WHICH IS A BEST WAY TO TREAT SUBACROMIAL IMPINGEMENT SYNDROME? A RANDOMIZED STUDY

Actual Study Start Date :

Jun 1, 2015

Actual Primary Completion Date :

Nov 1, 2015

Actual Study Completion Date :

Apr 1, 2016

Arms and Interventions

Arm	Intervention/Treatment
Experimental: IONTOPHORESIS The group that received 75 mg diclofenac sodium with Chattanooga Physio device.	Procedure: Iontophoresis Intervention Iontophoresis was applied with a Chattanooga Physio (DJO Global, Herentals, Belgium) brand device. The galvanic current mode was selected for the intervention. Intervention area was cleaned to prevent irritation and active electrode pad (cathode-5 cm2) was immersed in 75 mg diclofenac sodium solution. The current intensity of the application for 10 minutes was 0.1-0.2 mA/cm2. Procedure: Conventional Therapy All groups received a treatment program consisting of hot pack, Transcutaneous Electrical Nerve Stimulation and Shoulder girdle exercises for 30 minutes.
Experimental: PHONOPHORESIS It is a treatment performed by applying 75 mg of 1% diclofenac sodium gel to the intervention area with the Chattanooga ultrasound device.	Procedure: Phonophoresis Phonophoresis was performed with a Chattanooga brand ultrasound device (Chattanooga, Intelect Legend Ultrasound, TN, USA). 75 mg gel containing 1% diclofenac sodium was applied to the shoulder area. The ultrasound was conducted continuously for 6 minutes with frequency of 1 MHz and an intensity of 1.5 watts/cm2. Procedure: Conventional Therapy All groups received a treatment program consisting of hot pack, Transcutaneous Electrical Nerve Stimulation and Shoulder girdle exercises for 30 minutes.

Arm

Intervention/Treatment

Experimental: IONTOPHORESIS

The group that received 75 mg diclofenac sodium with Chattanooga Physio device.

Procedure: Iontophoresis Intervention

Iontophoresis was applied with a Chattanooga Physio (DJO Global, Herentals, Belgium) brand device. The galvanic current mode was selected for the intervention. Intervention area was cleaned to prevent irritation and active electrode pad (cathode-5 cm2) was immersed in 75 mg diclofenac sodium solution. The current intensity of the application for 10 minutes was 0.1-0.2 mA/cm2.

Procedure: Conventional Therapy

All groups received a treatment program consisting of hot pack, Transcutaneous Electrical Nerve Stimulation and Shoulder girdle exercises for 30 minutes.

Experimental: PHONOPHORESIS

It is a treatment performed by applying 75 mg of 1% diclofenac sodium gel to the intervention area with the Chattanooga ultrasound device.

Procedure: Phonophoresis

Phonophoresis was performed with a Chattanooga brand ultrasound device (Chattanooga, Intelect Legend Ultrasound, TN, USA). 75 mg gel containing 1% diclofenac sodium was applied to the shoulder area. The ultrasound was conducted continuously for 6 minutes with frequency of 1 MHz and an intensity of 1.5 watts/cm2.

Procedure: Conventional Therapy

All groups received a treatment program consisting of hot pack, Transcutaneous Electrical Nerve Stimulation and Shoulder girdle exercises for 30 minutes.

Outcome Measures

Primary Outcome Measures

Visual Analog Scale [At the baseline]
This scale assess the pain of the patients. The scale is scored from 0-10, with 0 indicating no pain and 10 indicating intolerable pain.
Visual Analog Scale [Immediately after 10 physiotherapy sessions on consecutive days]
This scale assess the pain of the patients. The scale is scored from 0-10, with 0 indicating no pain and 10 indicating intolerable pain.

Secondary Outcome Measures

Sociodemographic Data Form [At the baseline]
It is a form containing the descriptive characteristics of the patients.
Range of Motion [At the baseline]
The angular values of flexion, extension, abduction, internal and external rotation performed actively by the patients were examined with a universal goniometer.
Range of Motion [Immediately after 10 physiotherapy sessions on consecutive days]
The angular values of flexion, extension, abduction, internal and external rotation performed actively by the patients were examined with a universal goniometer.
Shoulder Disability Questionnaire [At the baseline]
This scale is a sixteen-item scale that assesses disability in individuals with shoulder complaints
Shoulder Disability Questionnaire [Immediately after 10 physiotherapy sessions on consecutive days]
This scale is a sixteen-item scale that assesses disability in individuals with shoulder complaints
Quick-Disabilities of the Arm, Shoulder and Hand Questionnaire [At the baseline]
In the scale, the functional status of individuals with shoulder pathology is questioned during their daily activities, and it is an assessment form filled by the patients themselves.
Quick-Disabilities of the Arm, Shoulder and Hand Questionnaire [Immediately after 10 physiotherapy sessions on consecutive days]
In the scale, the functional status of individuals with shoulder pathology is questioned during their daily activities, and it is an assessment form filled by the patients themselves.

Eligibility Criteria

Criteria

Ages Eligible for Study:

18 Years to 65 Years

Sexes Eligible for Study:

All

Accepts Healthy Volunteers:

Inclusion Criteria:

Patients diagnosed with Stage I-II SIS
The ages between 18 and 65 years

Exclusion Criteria:

Having underwent shoulder surgery,
Participated in a shoulder-related treatment program within the previous six months,
Failed to adhere to the treatment program by 70% or more